Recent studies indicate that ketogenic nutrition targets multiple neurobiological mechanisms associated with the development of Alzheimer’s disease, such as defects in mitochondrial function, cerebrospinal fluid biomarkers, insulin signaling, and dysfunctional glucose and lipid metabolism [3, 6, 7]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.